Effective 1/1/18, Cigna will no longer cover the long-acting opioid, OxyContin. Please note: This change does not affect OxyContin users in hospice or active cancer treatment. These customers will continue to receive coverage for their medication.

We sent a letter to customers who have filled a prescription for OxyContin within the last 120 days. The letter explained the coverage change to their current medication and provided information on covered alternatives, including Xtampza ER. On Cigna's formularies, Xtampza ER is the only covered long-acting preferred brand oxycodone option available to customers. We are encouraging customers who would like to remain on an oxycodone product to talk with their physician about switching to Xtampza ER. We have included the U.S. Food and Drug Administration’s dosing chart on the next page which shows the conversion to Xtampza ER. This chart is designed to assist pharmacists and physicians with prescribing Xtampza ER to their patients currently on OxyContin.

*Please see attached for more information.